查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840786

核酸分離純化市場按產品類型、技術、樣品類型、應用和最終用戶分類－2025-2032年全球預測

Nucleic Acid Isolation & Purification Market by Product Type, Technology, Sample Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，核酸分離純化市場規模將達到 161.6 億美元，複合年成長率為 9.92%。

關鍵市場統計數據
基準年 2024 75.8億美元
預計年份：2025年 83.2億美元
預測年份 2032 161.6億美元
複合年成長率 (%) 9.92%

介紹核酸分離純化在研究、診斷和治療開發平臺中的策略重要性

核酸分離和純化是許多現代生命科學工作流程的基礎，它能夠實現可靠的下游分子分析，從而推動發現、診斷和治療開發。自動化、化學和樣品處理技術的進步正在重塑實驗室操作，而定序、基於PCR的檢測和臨床檢測的融合則凸顯了穩健、可重複萃取平台的重要性。隨著實驗室優先考慮通量、一致性和污染控制，樣品製備步驟中的選擇對數據品質和操作效率有顯著影響。

本導言從三個營運維度建構了分離純化流程的宏觀框架：技術選擇與應用、產品和服務交付模式，以及學術界、臨床和工業實驗室的終端用戶需求。它重點闡述了磁珠化學和自動化工作站等技術創新如何與不斷變化的監管預期和實驗室規模相互作用。透過闡明術語和應用案例，本節為更深入地探討變革性轉變、關稅影響、市場細分洞察、區域動態、公司策略以及為尋求最佳化產能和提升韌性的相關人員提供的可行建議組裝了基礎。

深入探討自動化、磁珠化學和整合工作流程如何重塑核酸萃取實務和實驗室預期

由於技術成熟、工作流程整合以及終端用戶需求的變化，核酸分離純化領域正在經歷變革。在許多中高通量環境中，自動化已從可選項變為必需品，自動化工作站擴大與磁珠化學方法相結合，以提高結果的一致性、減少人工操作時間並實現可擴展的樣品處理。磁珠法曾因其靈活性和易於自動化而備受青睞，如今已與柱層析法和過濾法並存，為實驗室提供了在速度、純度和單次樣品成本之間進行權衡的頻譜。

同時，樣本多樣性和應用複雜性重塑了產品開發。臨床診斷和次世代定序對核酸完整性和抑制劑去除提出了更高的要求，促使供應商最佳化血液、細胞和組織基質的化學方法。套件和試劑不斷發展，以支援標靶定序、轉錄組學和全基因組應用，儀器製造商也強調模組化設計，以滿足不同的通量需求。隨著科技的發展，服務模式也在改變。合約研究組織和核心實驗室正在提供標準化的提取服務，降低了小型實驗室的進入門檻。總而言之，這些趨勢表明，提取工具正從單一的解決方案轉向整合式、檢驗的工作流程，以滿足可重複性、法規和規模化要求。

對美國於2025年實施的關稅如何促使供應鏈重組、採購轉移和庫存恢復策略進行全面評估

2025年源自美國的政策轉變和貿易行動為全球核酸分離純化供應鏈引入了新的變數。關稅調整提高了到岸成本和交貨的前置作業時間，從而影響了儀器、套件、試劑和耗材的籌資策略。為此，許多實驗室和供應商重新評估了其採購計劃，重點關注供應商多元化、本地庫存緩衝以及區域製造夥伴關係關係，以降低跨境關稅波動帶來的風險。

關稅環境也加速了圍繞供應鏈韌性和成本最佳化的討論。採購團隊權衡了維持較高國內庫存與現金流量影響和倉儲需求之間的利弊。同時，一些供應商尋求近岸外包或重組其分銷網路，以確保向無法承受中斷的臨床診斷實驗室和受託研究機構提供可靠的供貨。監管合規和品管仍然是不可妥協的，這促使企業加大對文件記錄和驗證方面的投入，以支持替代採購。總體而言，關稅促進了策略性供應鏈重組，凸顯了敏捷性、透明度和與供應商的長期合作對於持續獲得關鍵提取產品和服務的重要性。

關鍵的細分洞察揭示了產品類型、技術、樣品矩陣、應用重點和最終用戶需求如何影響產品策略和採用。

在核酸分離純化領域，了解市場區隔對於建立能夠滿足不同客戶需求的、具有針對性的產品策略和商業性模式至關重要。產品類型細分對於實驗室採購人員來說非常重要，因為他們可以根據通量和驗證要求，在儀器、套件、試劑和服務之間進行選擇。儀器包括自動化工作站和純化儀器，而套件和試劑包括磁珠試劑套件和離心柱試劑套件，它們在操作上各有優劣。諸如柱狀分離、過濾、磁珠分離和沈澱等技術，決定了下游檢測的兼容性、操作時間和與自動化平台的整合。血液、細胞和組織等樣本類型對裂解、抑制劑去除和核酸完整性提出了基質特異性要求，從而推動了化學方法和通訊協定的最佳化。

診斷、基因表現分析、次世代定序和PCR/RT-PCR各自對效能和驗證標準有不同的要求。在診斷領域，癌症診斷、遺傳疾病檢測和感染疾病診斷的需求各不相同，都需要量身定做的工作流程，以平衡靈敏度、特異性和周轉時間。次世代定序儀又分為標靶定序、轉錄組定序和全基因組定序，而輸入樣本的品質和片段大小會影響萃取方法的選擇。最終使用者細分凸顯了採​​購週期和應用程式路徑的差異。學術研究機構重視靈活性和方法透明度，臨床診斷實驗室需要嚴格的驗證和持續性，合約研究組織優先考慮通量和可重複性，而製藥和生物技術公司則需要可擴展的、符合GMP規範的工作流程。這些相互交織的細分體現在產品藍圖、市場推廣策略以及支援不同實驗室環境下應用和檢驗的服務。

深入剖析區域競爭與營運，闡釋美洲、歐洲、中東和非洲以及亞太地區如何以獨特的方式推動產品應用和供應鏈優先事項的發展。

在核酸分離純化領域，區域動態對技術應用、監管協調和供應鏈設計產生了顯著影響。在美洲，成熟的臨床診斷基礎設施和雄厚的科學研究經費推動了對可與高通量定序和PCR平台整合的、經過驗證的提取流程的需求。西歐部分地區強調嚴格的監管合規性和實驗室認證，而該地區的新興市場則正經歷著由不斷擴大的臨床檢測能力和研發投入所驅動的日益成長的需求，因此需要可擴展且經濟高效的提取解決方案。在亞太地區，基因組研究的快速發展、臨床實驗室網路的不斷擴展以及蓬勃發展的生物技術產業，推動了對自動化平台和本地化試劑供應的濃厚興趣，同時也促使人們更加關注支持區域檢驗和服務覆蓋的夥伴關係。

在這些全部區域，報銷機制、採購週期和實驗室基礎設施的差異會影響哪些技術和經營模式能夠成功。尤其對於大批量臨床檢測而言，區域性的生產和分銷能力在確保及時獲得耗材和設備方面發揮著至關重要的作用。因此，供應商正日益根據區域調整其商業性策略，將本地化的技術支援和檢驗資源與靈活的物流解決方案相結合，以滿足學術中心、臨床實驗室、合約研究機構 (CRO) 和行業客戶的多元化需求。

企業級策略洞察揭示了產品創新、檢驗的工作流程和服務模式如何重塑競爭定位和商業策略。

核酸分離純化生態系統中的主要企業正致力於透過產品創新、策略夥伴關係和服務拓展來保障淨利率並深化客戶關係。許多供應商正投資研發易於自動化操作的化學試劑和模組化儀器設計，從而降低各種規模實驗室採用這些技術的門檻。目前，企業策略重點明確放在開發經驗證的工作流程上，將萃取性能與下游檢測結果連結起來，使供應商能夠將產品定位為端到端解決方案，而非僅僅是獨立的試劑或儀器。

商業性策略包括加強分銷網路、拓展技術支援和培訓，以及為臨床和研究客戶提供特定應用的驗證方案。供應商也在探索訂閱和耗材付費模式，以穩定需求並提高可預測性。同時，一些公司正在建立或與服務機構合作，提供電子即服務 (eaaS) 解決方案，以解決客戶的產能限制並創造差異化的收入來源。試劑配方、儀器自動化演算法和品質系統方面的智慧財產權是競爭優勢，有助於在受監管市場中實現高階定位。

為製造商和服務提供者提供切實可行的建議，以加速產品採用、增強韌性並確保長期客戶價值。

產業領導者可以採取以下幾項切實可行的措施來增強韌性、加速產品普及並提供滿足不斷變化的實驗室需求的產品：在設計儀器和套件時優先考慮與模組化自動化系統的兼容性，使客戶能夠在不大幅更改實驗方案的情況下擴展通訊協定；投資最佳化磁珠化學以及離心柱和沈澱方案，以確保產品系列滿足各種樣品和通量需求；加強關鍵應用（特別是診斷和次世代定序）的技術檢驗方案，使客戶能夠受益於更快的部署速度和更清晰的性能預期。

從商業性角度來看，各組織正透過建立多元化的採購管道和區域性分銷協議，提升區域供應鏈的靈活性，以應對關稅和物流中斷等挑戰。拓展附加價值服務，例如方法轉移支援、現場培訓和萃取即服務，將加深客戶參與並創造持續收入。此外，提高品管和監管文件的透明度，有助於推動臨床應用，並加快受法規環境下的採購決策。這些措施的結合將使各組織能夠掌握由自動化、複雜應用以及對可重複性和合規性日益重視所驅動的需求。

我們透明的調查方法，詳細說明了主要研究、次要綜合和檢驗步驟，使我們能夠獲得可重複和可操作的研究結果。

本報告的研究基於多層次的調查方法，該方法結合了初步的定性研究和嚴謹的二手分析，並輔以結構化的三角驗證，以確保結論的可靠性。初步研究包括對來自學術研究中心、臨床診斷實驗室、委外研發機構以及製藥和生物技術公司的實驗室負責人、採購負責人和技術專家的訪談。這些訪談揭示了他們在通量、驗證和供應鏈方面的實際優先事項，檢驗了從已發表的方案文獻和監管指導文件中得出的假設。

二次研究包括對同行評審期刊、行業白皮書、技術應用說明和公開監管文件進行系統性回顧，以梳理技術性能特徵和應用適用性。資料綜合涉及交叉引用不同來源的觀點，識別一致主題，並消除不一致之處。品質保證通訊協定包括多次內部審查、專家檢驗，並透過記錄訪談指南和納入標準調查方法的透明度。最終的研究成果強調可重複性、對不同終端使用者的適用性以及對評估核酸分離純化策略的決策者的實際意義。

綜合運用技術進步、供應鏈現況及最終使用者期望等研究成果，為相關人員闡明策略要務。

核酸分離純化技術融合了創新與實用性，自動化、磁珠化學和整合工作流程正推動其在科研和臨床領域的應用。終端用戶日益尋求高效、可擴展的解決方案，以縮短週轉時間，同時確保核酸完整性，滿足次世代定序和高靈敏度診斷檢測等高要求下游應用的需求。供應鏈動態和區域差異進一步影響採購和部署策略，促使供應商和實驗室尋求多元化的採購管道和本地支援。

展望未來，將產品開發與模組化自動化、應用特定驗證和彈性供應鏈網路結合的相關人員，將更有能力滿足不斷變化的實驗室需求。對服務產品和區域佈局的策略性投資，能夠有效補充產品創新，並有助於建立持久的客戶夥伴關係和業務連續性。這些結論強調，在這個領域取得成功，可靠的執行和客戶支援與技術性能同樣重要。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將磁珠技術整合到全自動樣品製備平台中，用於高通量診斷
  • 在分散式環境下採用微流體晶片系統進行快速照護現場核酸萃取
  • 開發常溫穩定試劑，以減少現場基因檢測工作流程中對低溫運輸的依賴性
  • 推出一款單細胞RNA分離試劑套件，該試劑盒針對超低起始量和高轉錄組覆蓋率進行了最佳化。
  • 擴展直接裂解方法，簡化病毒RNA萃取流程，並實現隔日感染疾病監測。
  • 在基因組樣本純化流程中應用人工智慧驅動的通訊協定最佳化技術，以提高產量和純度
  • 擴大基於96孔盤和384孔盤的純化試劑套件的生產規模，以滿足臨床實驗室應對疫情規模檢測的需求
  • 將綠色化學方法整合到裂解緩衝液中，以最大限度地減少分子生物學中危險廢棄物的產生。
  • 為農業中的多重植物病原體檢測客製化自動化核酸萃取工作站
  • 奈米孔相容萃取方法的進步提高了長讀定序在結構變異分析中的品質。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依產品類型分類的核酸分離純化市場

  • 裝置
    • 自動化工作站
    • 精煉設備
  • 套件和試劑
    • 磁珠套件
    • 旋轉柱套件
  • 服務

第9章 核酸分離純化市場：依技術分類

  • 柱子
  • 篩選
  • 磁珠
  • 沉澱

第10章 依樣本類型分類的核酸分離純化市場

  • 血
  • 細胞
  • 組織

第11章 核酸分離純化市場：依應用領域分類

  • 診斷
    • 癌症診斷
    • 基因疾病檢測
    • 感染疾病診斷
  • 基因表現分析
  • 次世代定序
    • 標靶定序
    • 轉錄組定序
    • 全基因組序列分析
  • PCR RT-PCR

第12章 核酸分離純化市場（依最終用戶分類）

  • 學術研究機構
  • 臨床診斷實驗室
  • 合約研究組織
  • 製藥和生物技術公司

第13章 核酸分離純化市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 核酸分離純化市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國核酸分離純化市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Agilent Technologies Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Perkin Elmer Inc.
    • Promega Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
    • Norgen Biotec Corp.
    • Genaxxon bioscience GmbH
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd.
Product Code: MRR-783E443AFB64

The Nucleic Acid Isolation & Purification Market is projected to grow by USD 16.16 billion at a CAGR of 9.92% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.58 billion
Estimated Year [2025] USD 8.32 billion
Forecast Year [2032] USD 16.16 billion
CAGR (%) 9.92%

Introduction framing the strategic importance of nucleic acid isolation and purification across research, diagnostics, and therapeutic development pipelines

Nucleic acid isolation and purification underpin many contemporary life sciences workflows, enabling reliable downstream molecular analyses that drive discovery, diagnostics, and therapeutic development. Advances in automation, chemistry, and sample processing have reshaped laboratory practices, while the convergence of sequencing, PCR-based assays, and clinical testing has elevated the profile of robust, reproducible extraction platforms. As laboratories prioritize throughput, consistency, and contamination control, the choices made at the sample preparation stage exert outsized influence on data quality and operational efficiency.

This introduction frames the broader landscape by situating isolation and purification processes within three operational axes: technology selection and adoption; product and service delivery models; and end-user needs across academic, clinical, and industry laboratories. It emphasizes how innovations-such as magnetic bead chemistry and automated workstations-interact with regulatory expectations and shifting laboratory footprints. By clarifying terminology and use cases, this section sets the stage for more detailed discussion of transformative shifts, tariff impacts, segmentation insights, regional dynamics, company strategies, and actionable recommendations for stakeholders seeking to optimize capacity and resilience.

Detailed exploration of how automation, magnetic bead chemistry, and integrated workflows are reshaping nucleic acid extraction practices and laboratory expectations

The landscape of nucleic acid isolation and purification has undergone a transformative shift driven by technological maturation, workflow integration, and changing end-user priorities. Automation has moved from optional to essential in many mid-to-high throughput settings, with automated workstations increasingly paired with magnetic bead chemistries to deliver consistency, reduce hands-on time, and enable scalable sample processing. Magnetic bead approaches, favored for flexibility and amenability to automation, now coexist with column and filter methods, offering laboratories a spectrum of trade-offs between speed, purity, and cost per sample.

Concurrently, sample diversity and application complexity have reshaped product development. Clinical diagnostics and next generation sequencing exert high demands for nucleic acid integrity and inhibitor removal, incentivizing suppliers to optimize chemistries for blood, cellular, and tissue matrices. Kits and reagents are evolving to support targeted sequencing, transcriptomics, and whole genome applications, while instrument manufacturers focus on modularity to accommodate diverse throughput needs. Alongside technological evolution, service models have shifted: contract research organizations and core facilities increasingly offer standardized extraction services that lower barriers for smaller labs. Taken together, these trends signal a transition from point-solution extraction tools toward integrated, validated workflows designed to meet reproducibility, regulatory, and scale requirements.

Comprehensive assessment of how United States tariff measures introduced in 2025 catalyzed supply chain reengineering, procurement shifts, and inventory resilience strategies

Policy shifts and trade actions originating in the United States in 2025 introduced new variables into global supply chains that intersect with nucleic acid isolation and purification. Tariff adjustments influenced procurement strategies for instruments, kits, reagents, and consumables by increasing the visibility of landed costs and delivery lead times. In response, many laboratories and suppliers reassessed sourcing plans, placing greater emphasis on supplier diversification, local inventory buffers, and regional manufacturing partnerships to mitigate exposure to cross-border tariff volatility.

The tariff environment also accelerated conversations about supply chain resilience versus cost optimization. Procurement teams weighed the trade-offs inherent in maintaining larger domestic inventories against the cashflow impacts and storage requirements. Meanwhile, some suppliers pursued nearshoring and reconfiguration of distribution networks to preserve delivery reliability to clinical diagnostics laboratories and contract research organizations that cannot tolerate interruptions. Regulatory conformity and quality management remained non-negotiable, prompting investments in documentation and validation to support alternative sourcing. Overall, the tariffs acted as a catalyst for strategic supply chain reengineering and served to highlight the importance of agility, transparency, and long-term supplier collaboration in preserving uninterrupted access to critical extraction products and services.

Key segmentation insights revealing how product type, technology, sample matrix, application focus, and end-user needs converge to shape product strategies and adoption

Understanding segmentation is essential to crafting product strategies and commercial approaches that resonate with diverse customer needs across the nucleic acid isolation and purification space. Product type distinctions matter because laboratory buyers choose between instruments, kits and reagents, and services based on throughput and validation requirements; instruments span automated workstations and purification instruments, while kits and reagents include magnetic bead kits and spin column kits that present different operational trade-offs. Technology segmentation-covering column, filter, magnetic bead, and precipitation methods-shapes downstream assay compatibility, hands-on time, and integration with automation platforms. Sample type considerations such as blood, cells, and tissue impose matrix-specific demands on lysis, inhibitor removal, and nucleic acid integrity, driving the optimization of chemistries and protocols.

Application-driven segmentation further differentiates buyer priorities, with diagnostics, gene expression analysis, next generation sequencing, and PCR/RT-PCR each imposing distinct performance and validation criteria. Within diagnostics, needs diverge across cancer diagnostics, genetic disorder testing, and infectious disease diagnostics, each requiring tailored workflows that balance sensitivity, specificity, and turnaround time. Next generation sequencing splits into targeted sequencing, transcriptome sequencing, and whole genome sequencing, where input quality and fragment size considerations influence extraction choice. End-user segmentation highlights differences in procurement cycles and adoption pathways: academic and research institutes prize flexibility and method transparency; clinical diagnostics laboratories demand stringent validation and continuity; contract research organizations prioritize throughput and reproducibility; and pharmaceutical and biotechnology companies require scalable, GMP-aligned workflows. These intersecting segmentations inform product roadmaps, go-to-market tactics, and services that support adoption and validation across distinct laboratory environments.

Regional competitive and operational insights explaining how the Americas, Europe Middle East & Africa, and Asia-Pacific uniquely drive adoption and supply chain priorities

Regional dynamics exert a pronounced influence on technology adoption, regulatory alignment, and supply chain design across the nucleic acid isolation and purification domain. In the Americas, mature clinical diagnostics infrastructure and robust research funding foster demand for validated extraction workflows that integrate with high-throughput sequencing and PCR platforms; procurement decision-making often prioritizes time-to-result and regulatory conformity. Europe, Middle East & Africa present a heterogeneous landscape: parts of Western Europe emphasize stringent regulatory compliance and laboratory accreditation, while emerging markets within the region exhibit growing demand driven by expanding clinical testing capabilities and research investments, necessitating scalable and cost-effective extraction solutions. In Asia-Pacific, rapid investment in genomic research, expanding clinical testing networks, and a burgeoning biotechnology sector drive strong interest in automated platforms and localized reagent supply, alongside an emphasis on partnerships that support regional validation and service coverage.

Across these regions, differences in reimbursement frameworks, procurement cycles, and laboratory infrastructure influence which technologies and business models succeed. Regional manufacturing and distribution capabilities play an outsized role in ensuring timely access to consumables and instruments, particularly for high-volume clinical testing. As a result, suppliers increasingly tailor commercial approaches by region, combining localized technical support and validation resources with flexible logistics solutions to meet the divergent needs of academic centers, clinical laboratories, CROs, and industry customers.

Strategic company-level insights showing how product innovation, validated workflows, and service models are reshaping competitive positioning and commercial tactics

Leading companies in the nucleic acid isolation and purification ecosystem are pursuing a combination of product innovation, strategic partnerships, and service expansion to protect margins and deepen customer relationships. Many suppliers are investing in automation-compatible chemistries and modular instrument designs that reduce barriers to adoption across laboratories of varying scale. There is a clear strategic emphasis on developing validated workflows that link extraction performance to downstream assay outcomes, enabling vendors to position their offerings as end-to-end solutions rather than isolated reagents or devices.

Commercial tactics include strengthening distribution networks, expanding technical support and training offerings, and providing application-specific validation packages for clinical and research customers. Suppliers are also exploring subscription and consumable-based revenue models to stabilize demand and enhance predictability. In parallel, some companies are building or partnering with service organizations to offer extraction-as-a-service, which addresses capacity constraints for customers and generates differentiated revenue streams. Across these maneuvers, intellectual property in reagent formulations, instrument automation algorithms, and quality systems remains a competitive differentiator that supports premium positioning in regulated markets.

Actionable recommendations that manufacturers and service providers can implement to accelerate adoption, enhance resilience, and secure long-term customer value

Industry leaders can take several practical actions to strengthen resilience, accelerate adoption, and align offerings with evolving laboratory needs. Prioritize modular automation compatibility when designing instruments and kits so that customers can scale throughput without wholesale protocol changes. Invest in magnetic bead chemistry optimization alongside spin column and precipitation options to ensure product portfolios meet a variety of sample and throughput requirements. Strengthen technical validation packages for key applications-particularly diagnostics and next generation sequencing-so customers benefit from reduced implementation time and clearer performance expectations.

From a commercial perspective, cultivate regional supply chain flexibility by establishing multiple sourcing options and localized distribution agreements to guard against tariff and logistics disruptions. Expand value-added services such as method transfer support, on-site training, and extraction-as-a-service offerings to deepen customer engagement and create recurring revenue. Finally, enhance transparency around quality management and regulatory documentation to support clinical adoption and accelerate procurement decisions in regulated environments. These combined actions will help organizations capture demand driven by automation, complex applications, and an increased emphasis on reproducibility and regulatory compliance.

Transparent research methodology detailing primary engagement, secondary synthesis, and validation steps used to ensure reproducible and actionable insights

The research underpinning this report relied on a multilayered methodological approach combining primary qualitative engagement and rigorous secondary analysis, supplemented by structured triangulation to ensure robust conclusions. Primary research included interviews with laboratory leaders, procurement officers, and technical specialists across academic research centers, clinical diagnostics laboratories, contract research organizations, and pharmaceutical and biotechnology companies. These conversations illuminated real-world priorities around throughput, validation, and supply chain concerns, and served to validate assumptions drawn from published protocol literature and regulatory guidance documents.

Secondary research encompassed a systematic review of peer-reviewed journals, industry white papers, technical application notes, and public regulatory filings to map technology performance characteristics and application suitability. Data synthesis involved cross-referencing insights across sources to identify convergent themes and reconcile discrepancies. Quality assurance protocols included multiple rounds of internal review, expert validation, and methodological transparency with documented interview guides and inclusion criteria. The result is a research foundation that emphasizes reproducibility, applicability to diverse end-users, and practical relevance for decision-makers evaluating nucleic acid isolation and purification strategies.

Concluding synthesis that integrates technological advances, supply chain realities, and end-user expectations to clarify strategic imperatives for stakeholders

The conclusion synthesizes the principal themes: nucleic acid isolation and purification are at the intersection of technological innovation and operational pragmatism, where automation, magnetic bead chemistry, and integrated workflows drive adoption across research and clinical settings. End-users increasingly demand validated, scalable solutions that reduce hands-on time while safeguarding nucleic acid integrity for demanding downstream applications such as next generation sequencing and sensitive diagnostic assays. Supply chain dynamics and regional variations further influence procurement and deployment strategies, encouraging suppliers and laboratories to pursue diversified sourcing and localized support structures.

Looking forward, stakeholders who align product development with modular automation, application-specific validation, and resilient supply networks will be best positioned to meet evolving laboratory requirements. Strategic investments in service offerings and regional presence will complement product innovation, enabling sustained customer partnerships and operational continuity. These conclusions underscore that success in this domain is as much about dependable execution and customer support as it is about technical performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of magnetic bead technology in fully automated sample preparation platforms for high-throughput diagnostics
  • 5.2. Adoption of microfluidic chip systems enabling rapid point-of-care nucleic acid extraction in decentralized settings
  • 5.3. Development of ambient temperature stable reagents reducing cold chain dependency for field-based genetic testing workflows
  • 5.4. Emergence of single-cell RNA isolation kits optimized for ultra-low input and high transcriptome coverage
  • 5.5. Expansion of direct lysis methodologies streamlining viral RNA extraction for next-day infectious disease surveillance
  • 5.6. Implementation of AI-driven protocol optimizations improving yield and purity in genomic sample purification pipelines
  • 5.7. Scale-up of 96- and 384-well plate-based purification kits supporting pandemic-scale testing demands in clinical labs
  • 5.8. Integration of green chemistry approaches in lysis buffers minimizing hazardous waste generation in molecular biology
  • 5.9. Customization of automated nucleic acid extraction workstations for multiplexed plant pathogen detection in agriculture
  • 5.10. Advancements in nanopore-friendly extraction methods enhancing long-read sequencing quality for structural variant analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nucleic Acid Isolation & Purification Market, by Product Type

  • 8.1. Instruments
    • 8.1.1. Automated Workstations
    • 8.1.2. Purification Instruments
  • 8.2. Kits & Reagents
    • 8.2.1. Magnetic Bead Kits
    • 8.2.2. Spin Column Kits
  • 8.3. Services

9. Nucleic Acid Isolation & Purification Market, by Technology

  • 9.1. Column
  • 9.2. Filter
  • 9.3. Magnetic Bead
  • 9.4. Precipitation

10. Nucleic Acid Isolation & Purification Market, by Sample Type

  • 10.1. Blood
  • 10.2. Cells
  • 10.3. Tissue

11. Nucleic Acid Isolation & Purification Market, by Application

  • 11.1. Diagnostics
    • 11.1.1. Cancer Diagnostics
    • 11.1.2. Genetic Disorder Testing
    • 11.1.3. Infectious Disease Diagnostics
  • 11.2. Gene Expression Analysis
  • 11.3. Next Generation Sequencing
    • 11.3.1. Targeted Sequencing
    • 11.3.2. Transcriptome Sequencing
    • 11.3.3. Whole Genome Sequencing
  • 11.4. PCR RT-PCR

12. Nucleic Acid Isolation & Purification Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Clinical Diagnostics Laboratories
  • 12.3. Contract Research Organizations
  • 12.4. Pharmaceutical & Biotechnology Companies

13. Nucleic Acid Isolation & Purification Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Nucleic Acid Isolation & Purification Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Nucleic Acid Isolation & Purification Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Agilent Technologies Inc.
    • 16.3.2. Becton, Dickinson and Company
    • 16.3.3. Bio-Rad Laboratories, Inc.
    • 16.3.4. Merck KGaA
    • 16.3.5. Perkin Elmer Inc.
    • 16.3.6. Promega Corporation
    • 16.3.7. Takara Bio Inc.
    • 16.3.8. Thermo Fisher Scientific Inc.
    • 16.3.9. Norgen Biotec Corp.
    • 16.3.10. Genaxxon bioscience GmbH
    • 16.3.11. Danaher Corporation
    • 16.3.12. F. Hoffmann-La Roche Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NUCLEIC ACID ISOLATION & PURIFICATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NUCLEIC ACID ISOLATION & PURIFICATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NUCLEIC ACID ISOLATION & PURIFICATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION &